BRPI0816464A2 - Compostos de piperidimilamino-tieno[2,3-d]pirimidina para tratar fibrose - Google Patents

Compostos de piperidimilamino-tieno[2,3-d]pirimidina para tratar fibrose

Info

Publication number: BRPI0816464A2
Authority: BR; Brazil
Prior art keywords: piperidimilamino; tieno; pyrimidine compounds; treating fibrosis; fibrosis
Prior art date: 2007-09-04

Application number

Other languages

English (en)

Inventor

Kimberley Gannon

Philip B Graham

Original Assignee

Epix Delaware Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-09-04

Filing date

2008-09-04

Publication date

2015-03-24

2008-09-04 Application filed by Epix Delaware Inc filed Critical Epix Delaware Inc

2015-03-24 Publication of BRPI0816464A2 publication Critical patent/BRPI0816464A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Virology (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Communicable Diseases (AREA)
Gastroenterology & Hepatology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

BRPI0816464 2007-09-04 2008-09-04 Compostos de piperidimilamino-tieno[2,3-d]pirimidina para tratar fibrose BRPI0816464A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US96982007P	2007-09-04	2007-09-04
PCT/US2008/075193 WO2009032885A2 (en)	2007-09-04	2008-09-04	Piperidinylamino-thieno[2,3-d] pyrimidine compounds for treating fibrosis

Publications (1)

Publication Number	Publication Date
BRPI0816464A2 true BRPI0816464A2 (pt)	2015-03-24

Family

ID=40291329

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0816464 BRPI0816464A2 (pt)	2007-09-04	2008-09-04	Compostos de piperidimilamino-tieno[2,3-d]pirimidina para tratar fibrose

Country Status (11)

Country	Link
US (1)	US20100280050A1 (pt)
EP (1)	EP2194988A2 (pt)
JP (1)	JP2010538078A (pt)
KR (1)	KR20100072008A (pt)
CN (1)	CN101820882A (pt)
AU (1)	AU2008296308A1 (pt)
BR (1)	BRPI0816464A2 (pt)
CA (1)	CA2698377A1 (pt)
EA (1)	EA201070334A1 (pt)
MX (1)	MX2010002523A (pt)
WO (1)	WO2009032885A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9271980B2 (en) *	2009-08-03	2016-03-01	Daljit Singh Dhanoa	Deuterium-enriched pyrimidine compounds and derivatives
US10633336B2 (en)	2014-12-19	2020-04-28	The Broad Institute, Inc.	Dopamine D2 receptor ligands
EP3233799B1 (en)	2014-12-19	2021-05-19	The Broad Institute, Inc.	Dopamine d2 receptor ligands
EP4340940A4 (en) *	2021-05-20	2025-03-19	The Regents of University of California	COMPOSITIONS AND METHODS FOR TISSUE REGENERATION THERAPY

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20060013370A (ko) *	2003-03-31	2006-02-09	프레딕스 파마슈티컬스 홀딩즈, 인코포레이티드	신규한 피페리디닐아미노-티에노[2,3-ｄ]피리미딘 화합물
US7612078B2 (en) *	2003-03-31	2009-11-03	Epix Delaware, Inc.	Piperidinylamino-thieno[2,3-D] pyrimidine compounds
WO2007056214A2 (en) *	2005-11-02	2007-05-18	Cytovia, Inc	N-alkyl-n-aryl-thienopyrimidin-r-amines and uses thereof
WO2007084815A2 (en) *	2006-01-19	2007-07-26	Janssen Pharmaceutica, N.V.	Substituted thienopyrimidine kinase inhibitors

2008
- 2008-09-04 CA CA2698377A patent/CA2698377A1/en not_active Abandoned
- 2008-09-04 KR KR1020107007220A patent/KR20100072008A/ko not_active Withdrawn
- 2008-09-04 EA EA201070334A patent/EA201070334A1/ru unknown
- 2008-09-04 US US12/676,454 patent/US20100280050A1/en not_active Abandoned
- 2008-09-04 WO PCT/US2008/075193 patent/WO2009032885A2/en not_active Ceased
- 2008-09-04 MX MX2010002523A patent/MX2010002523A/es not_active Application Discontinuation
- 2008-09-04 AU AU2008296308A patent/AU2008296308A1/en not_active Abandoned
- 2008-09-04 BR BRPI0816464 patent/BRPI0816464A2/pt not_active Application Discontinuation
- 2008-09-04 CN CN200880111270A patent/CN101820882A/zh active Pending
- 2008-09-04 JP JP2010524131A patent/JP2010538078A/ja active Pending
- 2008-09-04 EP EP08799149A patent/EP2194988A2/en not_active Withdrawn

Also Published As

Publication number	Publication date
CN101820882A (zh)	2010-09-01
EP2194988A2 (en)	2010-06-16
KR20100072008A (ko)	2010-06-29
CA2698377A1 (en)	2009-03-12
JP2010538078A (ja)	2010-12-09
AU2008296308A1 (en)	2009-03-12
WO2009032885A2 (en)	2009-03-12
EA201070334A1 (ru)	2010-10-29
US20100280050A1 (en)	2010-11-04
WO2009032885A3 (en)	2009-04-30
MX2010002523A (es)	2010-08-31

Similar Documents

Publication	Publication Date	Title
DK2384326T3 (da)	2014-05-05	Pyrrolo[2,3-d]pyrimidinforbindelser
IL213787A0 (en)	2011-07-31	Substituted 5,6-dihydro-6-phenylbenzo[f] isoquinolin-2-amine compounds
DK2201012T3 (da)	2014-09-08	Pyrrolo[2,3-d]pyrimidinderivater som proteinkinase b-hæmmere
DK2350075T3 (da)	2014-05-26	Substituerede imidazo[1,2b]pyridazinforbindelser som trk-kinase-inhibitorer
BRPI0907563A2 (pt)	2015-08-04	Derivados de 4,5-di-hidro-xazol-2-il amina
DK3106463T6 (da)	2020-02-24	Pyrazolo[1,5-]pyrimidinforbindelse som trk-kinasehæmmer
DK2137184T3 (da)	2013-07-22	Imidazo[1,2-a]pyridinforbindelser som receptor-tyrosinkinaseinhibitorer
BRPI0822237A2 (pt)	2015-06-30	Compostos de imidazo [1,2-a] piridina
ZA201202718B (en)	2012-12-27	Pyrrolo[2,3-d]pyrimidine compounds
BRPI0811718A2 (pt)	2014-11-18	Derivados de 3,3-espiroindolinona
IL225694A0 (en)	2013-06-27	Compounds 6,5- dihydro-h1-pyridine-2-one
BRPI0922383A2 (pt)	2016-01-26	"aplicador de produto de acabamento para o assoalho".
BRPI0815059A2 (pt)	2015-02-10	Derivado de 1,3-di-hidroisoindol
BRPI0822239A2 (pt)	2015-06-30	Composto de pirazolo[1,5-a] pirimidina
BRPI0819668A2 (pt)	2015-05-26	Fresadora para fresagem de um brame
ZA200905065B (en)	2010-04-28	3-substituted-[1,2,3]benzotriazinone compounds for enhancing glutamatergic synaptic responses
IL201625A0 (en)	2010-05-31	Arylamide pyrimidone compounds
BRPI0915905A2 (pt)	2018-02-20	uso de derivados de pirimidilaminobenzamida para o tratamento de fibrose
BRPI0913644A2 (pt)	2015-11-24	processo para a prepração de derivados de pirimidina substituída.
BRPI0916395A2 (pt)	2016-02-16	compostos de 1,6-di-hidro-2h-3-oxa-6-aza-as-indaceno
BRPI0816464A2 (pt)	2015-03-24	Compostos de piperidimilamino-tieno[2,3-d]pirimidina para tratar fibrose
BRPI0818422A2 (pt)	2015-04-22	Processo para a preparação de melamina.
EP2511276A4 (en)	2012-12-19	Pyrrolo [2,3-D] pyrimidine derivative
IL206666A0 (en)	2010-12-30	N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2-
IL201444A0 (en)	2010-06-16	New 4, 8 - diphenyl - polyazanaphthalene derivatives

Legal Events

Date	Code	Title	Description
2015-06-09	B11A	Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
2015-09-08	B11Y	Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]